Capital Flow Monitor · Sponsors · CIK 1835579
Ikena Oncology, Inc.
645 Summer Street, Suite 101, BOSTON, MA, 02210 · 857-273-8343
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$75.0M
Sold
$0
% sold
0.0%
Investors
0
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-18 | D ·current | 506(b) | $75.0M | $0 | 0.0% | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Mark Manfredi — Executive Officer / Director, Boston, MA
- Jotin Marango — Executive Officer, Boston, MA
- Jeffrey Ecsedy — Executive Officer, Boston, MA
- David Bonita — Director, Boston, MA
- Iain Dukes — Director, Boston, MA
- Jean-Francois Formela — Director, Boston, MA
- Otello Stampacchia — Director, Boston, MA
- Maria Koehler — Director, Boston, MA
- Richard Wooster — Director, Boston, MA
- Owen Hughes — Director, Boston, MA
Placement agents
- Leerink Partners Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.